Rapid Nutrition (ALRPD) AI Stock Analysis

Rapid Nutrition

(Paris:ALRPD)

Select Model

Rating:38Underperform

Price Target:EUR 2.00▲(6.38% Upside)

Action:reiterated

Date:10/31/26

Primarily driven by weak financial performance with persistent losses and cash burn, followed by bearish technical indicators with price below key averages.

Positive Factors

Revenue ReboundThe TTM revenue rebound indicates that the company has recently regained some sales momentum after a difficult period. If sustained, stronger demand could improve operating leverage, support reinvestment, and provide a foundation for rebuilding profitability over the next several quarters.

Negative Factors

Persistent LossesPersistent losses and a negative net margin show that the business is not currently converting revenue into sustainable earnings. This weak profitability limits internal funding capacity, reduces resilience during operating setbacks, and makes a durable recovery dependent on significant improvement in margins.

Rapid Nutrition (ALRPD) vs. iShares MSCI France ETF (EWQ)

Market Cap: EUR 11.78M
Dividend Yield: ―
Average Volume (3M): 12.30K
Price to Earnings (P/E): -0.8
Beta (1Y): 1.20
Revenue Growth: -41.21%
EPS Growth: 73.08%
Country: France
Employees: 3
Sector: General
Sector Strength: 55
Industry: Packaged Foods

Rapid Nutrition Business Overview & Revenue Model

Company Description

Rapid Nutrition PLC is a natural healthcare enterprise that researches, develops, and manufactures a diverse portfolio of science-backed health and wellness products. Its market presence extends across the United Kingdom, Australia, Asia, the United...

Rapid Nutrition Financial Statement Overview

Summary

Weak income statement with collapsed margins and losses, poor cash flow with ongoing burn, partially offset by improved balance sheet leverage.

Income Statement

22Negative

Balance Sheet

48Neutral

Cash Flow

12Very Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	491.32K	194.33K	917.04K	1.66M	2.96M	2.79M
Gross Profit	122.53K	52.93K	482.09K	817.59K	2.08M	2.04M
EBITDA	-5.43M	-2.61M	-1.52M	-1.94M	-8.64M	594.14K
Net Income	-5.44M	-3.10M	-2.90M	-2.13M	-9.97M	238.07K
Balance Sheet
Total Assets	6.10M	9.07M	955.55K	918.27K	588.30K	2.62M
Cash, Cash Equivalents and Short-Term Investments	2.24M	8.55M	95.81K	488.10K	236.12K	77.51K
Total Debt	72.41K	77.87K	88.08K	194.87K	356.03K	2.12M
Total Liabilities	502.65K	549.66K	574.14K	877.66K	480.36K	3.53M
Stockholders Equity	5.59M	8.52M	381.41K	40.61K	107.94K	-909.79K
Cash Flow
Free Cash Flow	-5.43M	-3.12M	-3.00M	-1.55M	-2.36M	-146.36K
Operating Cash Flow	-5.43M	-3.12M	-3.00M	-1.55M	-2.36M	-146.36K
Investing Cash Flow	-2.95M	-1,545	0	0	0	11.16K
Financing Cash Flow	13.43M	11.59M	2.61M	1.80M	1.46M	-117.24K

Rapid Nutrition Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

FR:ALRPD against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:BOI	65Neutral	EUR 327.60M	12.55	6.82%	7.22%	-1.80%	35.22%
FR:ALFLE	56Neutral	EUR 98.62M	10.17	7.40%	14.32%	4.46%	133.27%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
FR:BLC	52Neutral	EUR 135.29M	2.34	49.70%	―	-1.79%	10979.07%
FR:BON	44Neutral	EUR 270.11M	17.87	-3.09%	2.98%	-0.80%	―
FR:SAVE	43Neutral	EUR 773.53M	9.81	4.13%	2.48%	-1.53%	-12.97%
FR:ALRPD	38Underperform	EUR 11.78M	-0.84	-77.10%	―	-41.21%	73.08%

* General Sector Average

Performance Comparison

FR:ALRPD and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
FR:ALRPD	Rapid Nutrition	1.88	-2.47	-56.78%
FR:BLC	Bastide le Confort Medical	18.50	-6.20	-25.10%
FR:BOI	Boiron SA	18.70	-7.98	-29.92%
FR:BON	Bonduelle SA	8.40	-0.34	-3.85%
FR:ALFLE	Fleury Michon	23.60	-0.42	-1.75%
FR:SAVE	Savencia SA	56.40	-4.03	-6.66%

Rapid Nutrition Corporate Events

Rapid Nutrition Posts Record Q3 as Accelerated Growth Strategy Takes Hold

Sep 29, 2026

Rapid Nutrition PLC reported a record trading quarter for the three months to 30 September 2026, generating unaudited average Group revenue of about $1 million per month. This represents an increase of more than 1,000% over its FY2025 average monthly...

Rapid Nutrition posts surging H1 revenue and expands via HealthShop+ acquisition

Sep 8, 2026

Rapid Nutrition has reported unaudited interim results for the six months to 30 June 2026, showing a 227.5% increase in revenue and a 122.3% rise in gross profit versus the prior year period. The performance was driven largely by its established bran...

Rapid Nutrition triples H1 revenue and expands with HealthShop+ acquisition

Sep 8, 2026

Rapid Nutrition reported a 227.5% year-on-year increase in first-half revenue and a 122.3% rise in gross margin, driven primarily by its historic brands as it executes a strategic refocus begun in 2025. The company also continued to invest heavily in...

Rapid Nutrition Wins Global Media Spotlight for AI-Driven HealthTech Strategy

Aug 4, 2026

Rapid Nutrition is positioning itself at the nexus of artificial intelligence, personalized wellness and digital health, combining proprietary consumer insights, evidence-based nutrition and vertically integrated operations in a single HealthTech pla...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026

Rapid Nutrition AI Stock Analysis